As a Fortune 500 leader and the world’s foremost provider of diagnostic insights, Quest Diagnostics (NYSE: DGX) represents an elite, investment-grade "credit-tenant" opportunity (S&P: BBB+ / Moody’s: Baa1). Serving one in three adult Americans annually, Quest’s Patient Service Centers (PSCs) are high-velocity "medtail" anchors that drive consistent, recession-proof foot traffic to retail centers and medical office buildings. For landlords and brokers, a Quest Diagnostics lease offers a rare combination of long-term financial security and a "daily-needs" visitor profile that benefits neighboring pharmacy, grocery, and wellness tenants. Backed by 2026 revenue guidance of nearly $11.8 billion and a 15-year record of consecutive dividend increases, Quest is a resilient, tech-forward partner that enhances the institutional value and bankability of any premier real estate asset.